These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10820243)

  • 1. Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture.
    Kersh GJ; Engle DL; Williams CB; Allen PM
    J Immunol; 2000 Jun; 164(11):5675-82. PubMed ID: 10820243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.
    Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA
    J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-specific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity.
    Viret C; Janeway CA
    J Immunol; 2003 Jan; 170(1):201-9. PubMed ID: 12496401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide specificity of thymic selection of CD4+CD25+ T cells.
    Pacholczyk R; Kraj P; Ignatowicz L
    J Immunol; 2002 Jan; 168(2):613-20. PubMed ID: 11777953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
    Kwon H; Jun HS; Khil LY; Yoon JW
    J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.
    Volkmann A; Barthlott T; Weiss S; Frank R; Stockinger B
    J Exp Med; 1998 Sep; 188(6):1083-9. PubMed ID: 9743527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of a specific self-peptide: self-MHC class II complex is critical for positive selection of thymocytes expressing the D10 TCR.
    Dao T; Blander JM; Sant'Angelo DB
    J Immunol; 2003 Jan; 170(1):48-54. PubMed ID: 12496382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha beta TCRs differ in the degree of their specificity for the positively selecting MHC/peptide ligand.
    Kraj P; Pacholczyk R; Ignatowicz L
    J Immunol; 2001 Feb; 166(4):2251-9. PubMed ID: 11160279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
    Nasreen M; Ueno T; Saito F; Takahama Y
    J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition for specific intrathymic ligands limits positive selection in a TCR transgenic model of CD4+ T cell development.
    Wong P; Goldrath AW; Rudensky AY
    J Immunol; 2000 Jun; 164(12):6252-9. PubMed ID: 10843678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions.
    Desbarats J; Lapp WS
    J Exp Med; 1993 Sep; 178(3):805-14. PubMed ID: 8394404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive selection of thymocytes expressing the same TCR by different MHC ligands results in the production of functionally distinct thymocytes distinguished by differential expression of the heat stable antigen.
    Teh HS; Motyka B; Teh SJ
    J Immunol; 1998 Jan; 160(2):718-27. PubMed ID: 9551907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.
    Shanker A; Auphan-Anezin N; Chomez P; Giraudo L; Van den Eynde B; Schmitt-Verhulst AM
    J Immunol; 2004 Apr; 172(8):5069-77. PubMed ID: 15067090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD69 expression discriminates MHC-dependent and -independent stages of thymocyte positive selection.
    Hare KJ; Jenkinson EJ; Anderson G
    J Immunol; 1999 Apr; 162(7):3978-83. PubMed ID: 10201918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection.
    Dave VP; Allman D; Wiest DL; Kappes DJ
    J Immunol; 1999 May; 162(10):5764-74. PubMed ID: 10229809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiological ligand of positive selection is seen with high specificity.
    Irion S; Berg RE; Staerz UD
    J Immunol; 2000 May; 164(9):4601-6. PubMed ID: 10779763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR.
    Holmberg K; Mariathasan S; Ohteki T; Ohashi PS; Gascoigne NR
    J Immunol; 2003 Sep; 171(5):2427-34. PubMed ID: 12928390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.